Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23382)

• Formulation Name: Betaxolol Hydrochloride eq 0.25% base suspension
• Company: Novartis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Betaxolol	(DM6EUL5)	Hypertension	BA00-BA04	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Acrylic acid	(E00132)	6581	Other agent
Benzalkonium chloride	(E00536)	21988052	Antimicrobial preservative; Penetration agent; Solubilizing agent; Surfactant
Edetate disodium	(E00186)	8759	Complexing agent
Hydrochloric acid	(E00015)	313	Acidulant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Water	(E00035)	962	Solvent